Epidarex Capital Partners Limited (formerly Rock Spring Ventures) is an Edinburgh based venture capital firm investing in the life sciences and health technology sector in United States and United Kingdom. It prefers innovations from the educational sectors like universities. The company focuses on biotechnology, medical devices and pharmaceuticals, personalized medicine and diagnostics, and healthcare IT and services. As of 2019, the company has invested 23 times in 12 portfolio companies with three successful exits.
Timeline
Funded Companies
Company
Description
Industry
Website
Location
Edinburgh Molecular Imaging Limited is an Edinburgh-based developer of optical molecular imaging technology.
Macomics is an Edinburgh-based immuno-oncology company.
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Theolytics
January 7, 2021
www.prnewswire.com:443
/PRNewswire/ -- Theolytics, a UK biotech harnessing viruses to combat cancer, today announced the closing of a US $6.8 million (UK £5 million) Series A round....
FinSMEs
June 22, 2020
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
JD Alois
June 22, 2020
Crowdfund Insider
Click HERE to find out ⭐ The British Business Bank Commits £50 million to New Epidarex Capital III UK LP fund. | Crowdfund Insider: Global Fintech News, including Crowdfunding, Blockchain and more.
References
Company attributes
Industry
Company status
Active
Crunchbase
Pitchbook
Legal name
Epidarex Capital Partners LLC
